Cambridge, MA, United States of America

Yunjung Baek

This inventor holds 1 USPTO granted patent. Top assignee: Harvard College. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yunjung Baek. Retrieved from https://idiyas.com/inventor/yunjung-baek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yunjung Baek: Innovator in Organometallic Catalysis

Introduction

Yunjung Baek is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of organometallic chemistry, particularly in the development of catalysts for C—H bond functionalization.

Latest Patents

Yunjung Baek holds a patent for "Annulation catalysts via direct C—H bond amination." This patent discloses compounds, methods, reagents, systems, and kits for the preparation and utilization of monomeric or polymeric metal-based compounds. The metal-based compounds are organometallic catalysts composed of substituted dipyrrin ligands bound to transition metals. The disclosed organometallic catalysts can perform C—H bond functionalization catalysis to yield C—N bonds, generating substituted bicyclic, spiro, and fused nitrogen-containing heterocycles, which are common motifs in various pharmaceutical and bioactive molecules. He has 1 patent to his name.

Career Highlights

Yunjung Baek is affiliated with Harvard College, where he continues to advance research in organometallic catalysis. His work has implications for the development of new pharmaceuticals and bioactive compounds.

Collaborations

He has collaborated with notable colleagues, including Theodore Alexander Betley and Alexandre Mikhailine, contributing to a dynamic research environment.

Conclusion

Yunjung Baek's innovative work in organometallic catalysis exemplifies the intersection of chemistry and technology, paving the way for advancements in pharmaceutical development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…